istock-183060916
oonal / iStockphoto.com
19 February 2018Americas

Roche to make $1.9bn acquisition

Switzerland-based Roche has revealed plans to acquire a healthcare technology company for $1.9 billion.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
11 May 2018   Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.
Americas
20 June 2018   Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.
Americas
25 February 2019   Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.

More on this story

Americas
11 May 2018   Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.
Americas
20 June 2018   Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.
Americas
25 February 2019   Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.

More on this story

Americas
11 May 2018   Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.
Americas
20 June 2018   Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.
Americas
25 February 2019   Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.